Webinars
Industry Perspective: Defining the Optimal Clinical Supply Strategy for Cell/Gene Therapy Studies
Insight into the current level of integration between the manufacturing and supply chain used and sought by cell/gene therapy companies.
View Now
Executive Summary
Building a Flexible, Challenge Resistant and Patient Centric Clinical Supply Chain
Learn strategies to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges.
View Now
Webinars
Leveraging Effective Clinical Supply Strategies to Meet Complex Challenges in China and APAC ( Chinese )
How Catalent’s integrated and innovative model can help to ensure timely and optimal clinical supply execution in the APAC region.
View Now
Article
Optimizing Resupply to Reduce Risk of Late Phase Delays
Learn ways that clinical supply strategies for late phase vary from early phase.
View Now
Article
Comprehensive Clinical Supply Strategy for Compressed Timeline Trials
Strategies sponsors can enable with a supply partner in order to minimize project risk.
View Now
Article
The APAC Advantages
Cultural considerations when planning and implementing an APAC clinical supply strategy.
View Now
Offering Fact Sheet
Fastchain® Demand Led Supply
Summary: FastChain® demand led supply is a continuous GMP approach to secondary packaging, label printing and application, release, and regional distribution of patient kits to clinical sites based upon actual patient and site need. The FastChain® approach will...
View Now
Webinars
Innovative Solutions to Meet the Complex Pharmaceutical Supply Challenges
Summary: Integrated approach from development to clinical and benefits of working with a single integrated provider.
View Now
Webinars
Planning Ahead: Using Phase 1 to Anticipate Phase 2 Clinical Supply Challenges and Solutions
Summary: Utilizing an integrated solution with a single provider can help ensure a smooth transition from Phase 1 into Phase 2.
View Now
Webinars
Excellence in Operating Multi-Center Clinical Trials
Summary: As the clinical development market evolves rapidly in China, a rising number of multi-national companies are initiating early phase clinical trials in China in parallel with other sponsor countries.
View Now